Ginkgo Bioworks Holdings Quick Ratio 2020-2022 | DNA

Historical quick ratio values for Ginkgo Bioworks Holdings (DNA) over the last 10 years.
Ginkgo Bioworks Holdings Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2022-12-31 $1.45B $0.17B 8.36
2022-09-30 $1.46B $0.13B 11.67
2022-06-30 $1.59B $0.14B 11.78
2022-03-31 $1.70B $0.16B 10.66
2021-12-31 $1.72B $0.14B 12.76
2021-09-30 $1.81B $0.09B 20.01
2021-06-30 $0.00B $0.01B 0.00
2021-03-31 $0.00B $0.00B 0.00
2020-12-31 $0.00B 0.00
2020-09-30 $0.00B 0.00
2019-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.549B $0.478B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.576B 8.70
GSK (GSK) United Kingdom $75.923B 9.52
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.436B 19.34
Arcus Biosciences (RCUS) United States $1.194B 0.00
Biohaven (BHVN) United States $0.913B 0.00
Emergent Biosolutions (EBS) United States $0.394B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.152B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.012B 0.00